bioRxiv Science⌕ Search

Biology subjects

Ghaedi, M.

Publications and source records attributed to Ghaedi, M..

2 recordsLinked to original sources

Human CD127 negative ILC2s show immunological memory

Group 2 Innate Lymphoid Cells (ILC2s) serve as key players in type 2 immunity and contribute significantly to maintaining homeostasis and responding to inflammation. Notably, ILC2s are closely implicated in the development of allergic disorders like asthma. While previous research has demonstrated immunological memory in mouse ILC2s, it has remained unclear whether human ILC2s can acquire this form of memory. In this study, we demonstrate the persistence of CD45RO, a marker previously linked to inflammatory ILC2s, in resting ILC2s that have undergone prior activation. These cells concurrently reduce the expression of the canonical ILC marker CD127. Through in vitro experiments involving the isolation and stimulation of CD127-CD45RO+ ILC2s, we observed an augmented ability to produce cytokines and undergo proliferation. CD127-CD45RO+ ILC2s are found in both healthy and inflamed tissues and display a gene signature of cell activation. Memory ILC2s may play a significant role in chronic type 2 diseases, such as allergic asthma and atopic dermatitis. HIGHLIGHTS- Inflamed and healthy tissues contain CD127-ILC2s with a gene signature of cell activation - CD127-CD45RO+ ILC2s from healthy tissues show immunological memory features - Mouse memory ILC2s downregulate CD127 - In vitro stimulation of naive ILC2s generates memory CD127-CD45RO+ ILC2s

immunology↗

Human airway lineages derived from pluripotent stem cells reveal the epithelial responses to SARS-CoV-2 infection

There is an urgent need to understand how SARS-CoV-2 infects the airway epithelium and in a subset of individuals leads to severe illness or death. Induced pluripotent stem cells (iPSCs) provide a near limitless supply of human cells that can be differentiated into cell types of interest, including airway epithelium, for disease modeling. We present a human iPSC-derived airway epithelial platform, composed of the major airway epithelial cell types, that is permissive to SARS-CoV-2 infection. Subsets of iPSC-airway cells express the SARS-CoV-2 entry factors ACE2 and TMPRSS2. Multiciliated cells are the primary initial target of SARS-CoV-2 infection. Upon infection with SARS-CoV-2, iPSC-airway cells generate robust interferon and inflammatory responses and treatment with remdesivir or camostat methylate causes a decrease in viral propagation and entry, respectively. In conclusion, iPSC-derived airway cells provide a physiologically relevant in vitro model system to interrogate the pathogenesis of, and develop treatment strategies for, COVID-19 pneumonia. Highlights and eTOC blurbO_LISubsets of human iPSC-airway epithelial cells express SARS-Co-V entry factors ACE2 and TMPRSS2. C_LIO_LIiPSC-airway cells are permissive to SARS-CoV-2 infection via multiciliated cells. C_LIO_LISARS-CoV-2 infection of iPSC-airway leads to a robust interferon and inflammatory response. C_LIO_LIiPSC-airway is a physiologically relevant model to study SARS-CoV-2 infection. C_LI

cell biology↗